The P-Value Problem in Psychiatry
Stanford researcher writes that readers should check the effect size of results instead of looking at the p-value.
How Dissenting Voices are Silenced in Medicine
Researcher criticizes the many ways opposing viewpoints and dissenting voices are squashed in the field of medicine.
Researchers: Antidepressant Withdrawal, Not “Discontinuation Syndrome”
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
Biogen Pushes FDA to Approve Failed Alzheimer’s Drug
A new analysis, published in Lancet Neurology, demonstrates how Biogen is spinning results from two failed trials for a new Alzheimer's drug.
Researchers Set the Record Straight on Controversial Zoloft Study
An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).
Pervasive Industry Influence in Healthcare Sector Harms Patients
Experts across the globe point to the harms of drug companies’ influence on research, practice, and education in healthcare noting that it compromises patient care.
Despite Claims, EPA Supplement Does Not Improve ADHD Symptoms in Youth
A new study reports that the supplement EPA improved ADHD symptoms but a closer look calls these results into question.
Textbooks Provide Misleading Information on the Neurobiology of ADHD
When it comes to ADHD, some researchers suggest that medical textbooks provide inaccurate and misleading information.
Zoloft Does Not Improve Depression, Even in Severe Cases, Study Finds
Despite their finding, the researchers suggest that SSRIs be given to people who do not meet criteria for depression or anxiety.
Substantial Spin Found in Leading Psychology and Psychiatry Journals
: A new review finds evidence of spin and the misrepresentation of clinical trials with non-significant results.
Review Finds FDA Approval of Digital Antipsychotic Misguided
The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.
Teacher Perspectives on Student ADHD Medication Use
Qualitative study examines patterns in teacher attitudes and knowledge related to medication of students for ADHD-type behaviors.
Mobile Apps for Mental Health Lack Transparency in Data Sharing
Research illustrates privacy concerns with how mental health applications collect and share users’ data.
Fighting for the Meaning of Madness: An Interview with Dr. John Read
Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.
Researchers Find Bias in Industry-Funded Continuing Medical Education
Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.
Researchers Fail to Replicate Evidence for “Biotypes” of Depression
A new study casts doubt on whether such biotypes for depression exist.
Withdrawal Symptoms Routinely Confound Findings of Psychiatric Drug Studies
Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.
Adderall Use Associated with Increased Risk of Psychosis
Twice as many teenagers with ADHD experienced severe psychosis when taking Adderall, as compared to Ritalin, according to a new study.
Does Active Placebo Response Explain Antidepressant Results?
A new study investigated whether participants guessing if they have an antidepressant or placebo affects response rates.
It is Time to Abandon the Candidate-Gene Approach to Depression
The candidate-gene approach to depression goes unsupported and is likely based on bad science, new research finds.
First-Person Accounts of Madness and Global Mental Health: An Interview with Dr. Gail Hornstein
Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.
Mental Health Concerns Not “Brain Disorders,” Say Researchers
The latest issue of the journal Behavioral and Brain Sciences features several prominent researchers arguing that mental health concerns are not “brain disorders.”
How Do Clients Solicit Medication Changes With Psychiatrists?
Researchers examine psychiatrist-client interactions and find that clients are often left with few opportunities to make explicit requests to change their medication regimen.
Very Slow Tapering Best For Antidepressant Withdrawal
A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.
More Evidence for the Lasting Psychological Impact of Lead Exposure in Childhood
New research points to numerous harmful effects of high-level lead exposure in childhood on adult mental health and personality characteristics.